Skip to main content
. 2022 Sep 26;2022(9):CD015048. doi: 10.1002/14651858.CD015048.pub2

Comparison 11. PDS: LVRD (> 2 cm) versus RD < 2 cm (stage IV disease).

Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
11.1 Overall survival 2   Hazard Ratio (IV, Random, 95% CI) 1.63 [0.83, 3.23]
11.2 Progression‐free survival 1   Hazard Ratio (IV, Random, 95% CI) Subtotals only